Related Experiment Video
Updated: Mar 27, 2026
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
The Role of Advanced Lung Cancer Inflammation Index in Predicting COPD Exacerbation Risks
Wang Chun Kwok1, Sze Him Isaac Leung2, Terence Chi Chun Tam1
1Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, People's Republic of China.
Background:
The role of the Advanced Lung Cancer Inflammation Index (ALI) in chronic obstructive pulmonary disease (COPD) remains unclear, although it has been utilized to investigate various non-malignant conditions.
Methods:
A prospective study involving Chinese patients with COPD was carried out in Hong Kong to examine the relationship between baseline ALI levels and the risk of acute exacerbations of COPD (AECOPD). ALI was evaluated across quartiles. Patients were prospectively recruited from respiratory clinic in Queen Mary Hospital and Grantham Hospital in 2021, follow up with patients was done until 8th March 2025 or the death date, whichever is earlier.
Results:
Among 272 Chinese COPD patients recruited, 138 of them had moderate to severe AECOPD and 66 patients died in the follow-up period. Those in the Q1 ALI, when compared with Q4 (highest quartile), had significantly shorter time to moderate to severe AECOPD with adjusted hazard ratio of (aHR) 2.17 (95% CI = 1.29-3.65, p = 0.011), severe AECOPD (aHR 2.05, 95% CI = 1.18-3.55, p = 0.011) and overall survival (aHR 2.73, 95% CI = 1.21-6.15, p = 0.015). The same phenomenon was also observed in the patient subgroup with baseline blood eosinophil counts <300 cells/μL.
Conclusion:
In this prospective study, it suggested that ALI can serve as a biomarker to predict the risk of moderate to severe AECOPD, as well as severe AECOPD and mortality. The phenomenon was also observed in the non-eosinophilic subgroup. This can allow clinicians to use this simple and repeatable biomarker as a way to prognosticate COPD patients and estimate AECOPD risks.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...